NCT06408623 2024-05-10Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver CancerCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2 Not yet recruiting48 enrolled